New York State Common Retirement Fund’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-357
| Closed | -$40K | – | 3310 |
|
2020
Q1 | $40K | Hold |
357
| – | – | ﹤0.01% | 3026 |
|
2019
Q4 | $87K | Hold |
357
| – | – | ﹤0.01% | 3036 |
|
2019
Q3 | $123K | Hold |
357
| – | – | ﹤0.01% | 2974 |
|
2019
Q2 | $328K | Sell |
357
-201
| -36% | -$185K | ﹤0.01% | 2576 |
|
2019
Q1 | $891K | Sell |
558
-35
| -6% | -$55.9K | ﹤0.01% | 2024 |
|
2018
Q4 | $1.11M | Buy |
593
+139
| +31% | +$260K | ﹤0.01% | 1859 |
|
2018
Q3 | $1.07M | Hold |
454
| – | – | ﹤0.01% | 2052 |
|
2018
Q2 | $1.56M | Buy |
454
+62
| +16% | +$214K | ﹤0.01% | 1845 |
|
2018
Q1 | $1.11M | Hold |
392
| – | – | ﹤0.01% | 1966 |
|
2017
Q4 | $1.01M | Hold |
392
| – | – | ﹤0.01% | 2031 |
|
2017
Q3 | $1.11M | Hold |
392
| – | – | ﹤0.01% | 1951 |
|
2017
Q2 | $926K | Hold |
392
| – | – | ﹤0.01% | 2087 |
|
2017
Q1 | $987K | Hold |
392
| – | – | ﹤0.01% | 2039 |
|
2016
Q4 | $884K | Hold |
392
| – | – | ﹤0.01% | 2109 |
|
2016
Q3 | $981K | Buy |
392
+34
| +9% | +$85.1K | ﹤0.01% | 2001 |
|
2016
Q2 | $1.1M | Sell |
358
-896
| -71% | -$2.75M | ﹤0.01% | 1933 |
|
2016
Q1 | $3.98M | Buy |
1,254
+10
| +0.8% | +$31.7K | 0.01% | 1301 |
|
2015
Q4 | $6.38M | Buy |
1,244
+13
| +1% | +$66.7K | 0.01% | 1120 |
|
2015
Q3 | $3.92M | Sell |
1,231
-493
| -29% | -$1.57M | 0.01% | 1310 |
|
2015
Q2 | $6.9M | Sell |
1,724
-60
| -3% | -$240K | 0.01% | 1167 |
|
2015
Q1 | $7.12M | Hold |
1,784
| – | – | 0.01% | 1028 |
|
2014
Q4 | $8.75M | Sell |
1,784
-200
| -10% | -$981K | 0.01% | 933 |
|
2014
Q3 | $8.07M | Buy |
1,984
+43
| +2% | +$175K | 0.01% | 986 |
|
2014
Q2 | $7.85M | Buy |
1,941
+390
| +25% | +$1.58M | 0.01% | 1049 |
|
2014
Q1 | $7.06M | Buy |
1,551
+739
| +91% | +$3.36M | 0.01% | 1072 |
|
2013
Q4 | $2.85M | Buy |
812
+7
| +0.9% | +$24.5K | ﹤0.01% | 1475 |
|
2013
Q3 | $3.31M | Buy |
805
+24
| +3% | +$98.7K | 0.01% | 1346 |
|
2013
Q2 | $3.09M | Buy |
+781
| New | +$3.09M | 0.01% | 1269 |
|